Keyphrases
Absolute Lymphocyte Count
100%
Lymphopenia
100%
Severe COVID-19
100%
Increased Mortality
13%
Secondary Infection
13%
Severe COVID-19 Outcomes
13%
Viral
6%
Interleukin-6
6%
Management Strategy
6%
Lung
6%
Clinical Outcomes
6%
Heart Failure
6%
Old Age
6%
Hospitalization
6%
Immune Response
6%
Immunosuppression
6%
Male Sex
6%
Knowledge Gaps
6%
Logistic Regression
6%
Clinical Factors
6%
Proportional Hazards Model
6%
Organ Damage
6%
Clinical Variables
6%
Trial Participants
6%
Sustained Recovery
6%
Between-day
6%
Disease Pathogenesis
6%
Antigen Levels
6%
COVID-19
6%
Normal Body Mass Index
6%
Platform Trials
6%
Aspirin Use
6%
Underlying Risk Factors
6%
Fine-Gray Model
6%
Nucleocapsid Antigen
6%
Immunology and Microbiology
Lymphocyte Count
100%
Lymphocytopenia
100%
COVID-19
100%
Immune Response
6%
Body Mass
6%
Virus Nucleocapsid
6%
Immunosuppression
6%
Interleukin 6
6%
Medicine and Dentistry
Lymphocytopenia
100%
COVID-19
100%
Secondary Infection
13%
Biological Marker
6%
Body Mass Index
6%
Logistic Regression Analysis
6%
Immunosuppressive Treatment
6%
Proportional Hazards Model
6%
Interleukin 6
6%
Immune Response
6%
Congestive Heart Failure
6%
Acetylsalicylic Acid
6%
Post-Hoc Analysis
6%
Kidney Injury
6%
Virus Nucleocapsid
6%
Diseases
6%
Nursing and Health Professions
Lymphocytopenia
100%
Lymphocyte Count
100%
Secondary Infection
13%
Body Mass
6%
Logistic Regression Analysis
6%
Interleukin 6
6%
Proportional Hazards Model
6%
Clinical Outcome
6%
Biological Marker
6%
Post Hoc Analysis
6%
Congestive Heart Failure
6%
Immunosuppressive Treatment
6%
Kidney Injury
6%
Diseases
6%